Product NDC: | 0115-1476 |
Proprietary Name: | Imiquimod |
Non Proprietary Name: | Imiquimod |
Active Ingredient(s): | 50 mg/g & nbsp; Imiquimod |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-1476 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091044 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110228 |
Package NDC: | 0115-1476-23 |
Package Description: | 24 POUCH in 1 CARTON (0115-1476-23) > .25 g in 1 POUCH (0115-1476-59) |
NDC Code | 0115-1476-23 |
Proprietary Name | Imiquimod |
Package Description | 24 POUCH in 1 CARTON (0115-1476-23) > .25 g in 1 POUCH (0115-1476-59) |
Product NDC | 0115-1476 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Imiquimod |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20110228 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | IMIQUIMOD |
Strength Number | 50 |
Strength Unit | mg/g |
Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |